Saudi Arabia condemns Israeli settlement plans near East Jerusalem

Saudi Arabia condemns Israeli settlement plans near East Jerusalem
A view overlooks the Jewish West Bank settlement of Ari’el, January 28, 2020. (AP)
Short Url
Updated 17 November 2020

Saudi Arabia condemns Israeli settlement plans near East Jerusalem

Saudi Arabia condemns Israeli settlement plans near East Jerusalem

RIYADH: Saudi Arabia said Tuesday it was “gravely concerned” over Israel’s decision to push ahead with building hundreds of settlement homes near occupied East Jerusalem.
Israel on Sunday invited contractor bids for 1,257 units in Givat Hamatos as part of a settlement scheme revived in February.
Saudi Arabia’s Ministry of Foreign Affairs condemned and rejected the move, “which contravenes international resolutions, and that would undermine the two-state solution and affect peace efforts in the region.”
The Israeli announcement was condemned by Palestinians, the European Union and other Arab countries.


Dr. Iman Al-Mansour, assistant professor at the Institute for Research and Medical Consultations in Dammam

Dr. Iman Al-Mansour, assistant professor at the Institute for Research and Medical Consultations in Dammam
Updated 53 min 27 sec ago

Dr. Iman Al-Mansour, assistant professor at the Institute for Research and Medical Consultations in Dammam

Dr. Iman Al-Mansour, assistant professor at the Institute for Research and Medical Consultations in Dammam

Dr. Iman Al-Mansour is an assistant professor of epidemiology at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), in Dammam.

Al-Mansour led many research projects from conception to execution at the department of epidemic diseases research at IAU and supervised graduate students and junior scientists.

She acted as the principal investigator on a number of key research projects related to the development of nucleic acid-based vaccines, the establishment of several virus bioinformatics databases and analysis resources, and virus immune monitoring studies.

Al-Mansour believes that investment in vaccine research is an important step to combat epidemics and pandemics caused by new viruses. This is followed by the localization of the manufacturing of vaccines and biological medicines.

She served as a Ph.D. researcher at the nucleic acid vaccine (NAV) lab at the University of Massachusetts, US, where she conducted rigorous research in the design, generation, and testing of DNA vaccines expressing HA’s of influenza (H1N1) strains.

Al-Mansour’s research is focused on cutting-edge technology to develop prophylactic vaccines against emerging and re-emerging viruses.

She earned a Ph.D. in biomedical engineering and biotechnology from the University of Massachusetts, US, and a master’s degree in clinical laboratory sciences from the University of Rhode Island, US.

Al-Mansour received her bachelor’s in medical laboratory technology from IAU.

She is also an academic member at the European Virus Bioinformatics Center (EVBC), Germany, and a member at the International Society for Global health (ISoGH), in the UK.